- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06842238
Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation (BRONCHAD)
The occurrence of a first episode of acute bronchiolitis in an infant or young child (3 months-2 years) always represents a medical event that generates stress for parents and in some cases for the primary care physician when it is necessary to decide on the child's orientation for treatment. Each year, during the winter season, this pathology affects 30% of infants under two years old (480,000 annual cases in France), generates approximately 30,000 hospitalizations and exposes to an overall mortality risk of 0.08%.
According to the recommendations of the HAS (2019), moderate bronchiolitis does not require systematic hospitalization and can be managed in a Home Hospitalization (HAD) context.
When the child's examination data do not find signs of severity, the SpO2 measurement is greater than 92% and the family context allows for return home, HAD management is a reasonable option and represents an alternative to the classic scheme of assessing the level of severity by the emergency department and subsequent hospitalization if necessary. HAD management is carried out within the framework of a very structured "patient pathway", codified and supervised by the pediatric teams and doctors of this department. This patient pathway concerns children with a moderate form of bronchiolitis without oxygen requirements at the time of inclusion. This must be 48 hours from the onset of the child's respiratory clinical signs.
The main objective of this study is to describe the need for oxygen therapy for a young child with moderate acute bronchiolitis syndrome during home hospitalization (HAD) care.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Khaked Husseini, Dr
- Phone Number: 0549422617
- Email: recherche.na@elsan.care
Study Locations
-
-
-
Poitiers, France, 86000
- Recruiting
- Polyclinique de Poitiers - HAD
-
Contact:
- Khaled Husseini, Dr
- Phone Number: 0549422617
- Email: recherche.na@elsan.care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any infant with moderate bronchiolitis according to the HAS definition (except for the SpO2 criterion which must be greater than or equal to 92% to avoid the patient being on oxygen therapy upon admission)
- Age > 2 months and ≤ 2 years
- Respiratory syndrome for 48 hours
- Infant with a first episode of bronchiolitis
- Referral of the general practitioner/treating pediatrician for home hospitalisation care
- Parents' agreement for the choice of home hospitalisation care
- Non-opposition or free and informed consent of both parents to the use of the child's health data
Exclusion Criteria:
- Patient not receiving health protection
- Comorbidities: congenital heart disease with shunt, chronic pulmonary pathology including bronchopulmonary dysplasia, neuromuscular pathology, immune deficiency, multiple disabilities Congenital heart disease
- Refusal of one or both parents for the proposed pathway
- Doubts about the parents' understanding of the nature of home hospitalisation care
Severe bronchiolitis or with saturation < 92%
- Moderate bronchiolitis but evolving for less than 48 hours
- Cases of psychiatric pathologies or depressive syndrome diagnosed in the parents.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygenotherapy
Time Frame: one month
|
Need for oxygen therapy during home hospitalisation care
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen therapy assistance
Time Frame: up to one month
|
Oxygen therapy assistance during home hospitalization care
|
up to one month
|
|
Home hospitalization support
Time Frame: up to one month
|
Duration of home hospitalization support
|
up to one month
|
|
Hospitalization time
Time Frame: up to one month
|
hospitalization during home hospitalization care
|
up to one month
|
|
QUALIN questionnaire
Time Frame: day 1, day 7 and one month
|
QUALIN questionnaire is a 34-item scale to assess an infant's quality of life.
|
day 1, day 7 and one month
|
|
Hospital Anxiety and Depression Scale questionnaire
Time Frame: day 1, day 7 and one month
|
HADS questionnaire has 14 items between 0 and more than 11 points
|
day 1, day 7 and one month
|
|
Direct costs
Time Frame: day 1, day 7 and one month
|
daily cost of home hospitalization without oxygen, daily cost of home hospitalization with oxygen, GHS bronchiolitis level 2
|
day 1, day 7 and one month
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-A01404-43
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
Regend TherapeuticsShanghai Children's HospitalRecruitingPediatric Bronchiolitis ObliteransChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedBronchiolitis Obliterans Syndrome (BOS)Italy
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Dompé Farmaceutici S.p.ARecruitingAtopic KeratoconjunctivitisSpain, Italy, United States